Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Infant Hydrocephalus Outcomes in Uganda: Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure After ETV/CPC

NCT03650101 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03650101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Infant Hydrocephalus Outcomes in Uganda: Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure After ETV/CPC
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
May 5, 2021
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hydrocephalus